These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 16698097

  • 1. Anatomy changes in radiotherapy detected using portal imaging.
    McDermott LN, Wendling M, Sonke JJ, van Herk M, Mijnheer BJ.
    Radiother Oncol; 2006 May; 79(2):211-7. PubMed ID: 16698097
    [Abstract] [Full Text] [Related]

  • 2. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P, Ferreira BC, Shi C, Lind BK, Papanikolaou N.
    Phys Med Biol; 2007 Jul 07; 52(13):3817-36. PubMed ID: 17664579
    [Abstract] [Full Text] [Related]

  • 3. SIFT: a method to verify the IMRT fluence delivered during patient treatment using an electronic portal imaging device.
    Vieira SC, Dirkx ML, Heijmen BJ, de Boer HC.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):981-93. PubMed ID: 15465217
    [Abstract] [Full Text] [Related]

  • 4. Routine individualised patient dosimetry using electronic portal imaging devices.
    Nijsten SM, Mijnheer BJ, Dekker AL, Lambin P, Minken AW.
    Radiother Oncol; 2007 Apr 01; 83(1):65-75. PubMed ID: 17383761
    [Abstract] [Full Text] [Related]

  • 5. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
    Das IJ, Cheng CW, Chopra KL, Mitra RK, Srivastava SP, Glatstein E.
    J Natl Cancer Inst; 2008 Mar 05; 100(5):300-7. PubMed ID: 18314476
    [Abstract] [Full Text] [Related]

  • 6. Effects of geometric distortion in 0.2T MRI on radiotherapy treatment planning of prostate cancer.
    Petersch B, Bogner J, Fransson A, Lorang T, Pötter R.
    Radiother Oncol; 2004 Apr 05; 71(1):55-64. PubMed ID: 15066296
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of MLC leaf positioning using a scanning liquid ionization chamber EPID.
    Mohammadi M, Bezak E.
    Phys Med Biol; 2007 Jan 07; 52(1):N21-33. PubMed ID: 17183123
    [Abstract] [Full Text] [Related]

  • 8. Interfractional set-up errors evaluation by daily electronic portal imaging of IMRT in head and neck cancer patients.
    Pehlivan B, Pichenot C, Castaing M, Auperin A, Lefkopoulos D, Arriagada R, Bourhis J.
    Acta Oncol; 2009 Jan 07; 48(3):440-5. PubMed ID: 19031160
    [Abstract] [Full Text] [Related]

  • 9. Comparison of IMRT treatment plans between linac and helical tomotherapy based on integral dose and inhomogeneity index.
    Shi C, Peñagarícano J, Papanikolaou N.
    Med Dosim; 2008 Jan 07; 33(3):215-21. PubMed ID: 18674686
    [Abstract] [Full Text] [Related]

  • 10. Replacing pretreatment verification with in vivo EPID dosimetry for prostate IMRT.
    McDermott LN, Wendling M, Sonke JJ, van Herk M, Mijnheer BJ.
    Int J Radiat Oncol Biol Phys; 2007 Apr 01; 67(5):1568-77. PubMed ID: 17394951
    [Abstract] [Full Text] [Related]

  • 11. Phantom and in-vivo measurements of dose exposure by image-guided radiotherapy (IGRT): MV portal images vs. kV portal images vs. cone-beam CT.
    Walter C, Boda-Heggemann J, Wertz H, Loeb I, Rahn A, Lohr F, Wenz F.
    Radiother Oncol; 2007 Dec 01; 85(3):418-23. PubMed ID: 18023491
    [Abstract] [Full Text] [Related]

  • 12. Correction of conebeam CT values using a planning CT for derivation of the "dose of the day".
    van Zijtveld M, Dirkx M, Heijmen B.
    Radiother Oncol; 2007 Nov 01; 85(2):195-200. PubMed ID: 17936387
    [Abstract] [Full Text] [Related]

  • 13. [Megavoltage cone-beam CT: Recent developments and clinical applications].
    Pouliot J, Morin O, Aubin M, Aubry JF, Chen J, Speight J, Roach M.
    Cancer Radiother; 2006 Sep 01; 10(5):258-68. PubMed ID: 16861025
    [Abstract] [Full Text] [Related]

  • 14. 3D dose reconstruction for clinical evaluation of IMRT pretreatment verification with an EPID.
    van Zijtveld M, Dirkx ML, de Boer HC, Heijmen BJ.
    Radiother Oncol; 2007 Feb 01; 82(2):201-7. PubMed ID: 17287039
    [Abstract] [Full Text] [Related]

  • 15. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P, Laliberte B, Allaw A, Ailleres N, Idri K, Hay MH, Moscardo CL, Gourgou S, Dubois JB, Azria D.
    Radiother Oncol; 2008 Jul 01; 88(1):77-87. PubMed ID: 18215434
    [Abstract] [Full Text] [Related]

  • 16. The next step in patient-specific QA: 3D dose verification of conformal and intensity-modulated RT based on EPID dosimetry and Monte Carlo dose calculations.
    van Elmpt W, Nijsten S, Mijnheer B, Dekker A, Lambin P.
    Radiother Oncol; 2008 Jan 01; 86(1):86-92. PubMed ID: 18054102
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
    Ali I, Algan O, Thompson S, Sindhwani P, Herman T, Cheng CY, Ahmad S.
    Phys Med Biol; 2009 Sep 21; 54(18):5595-611. PubMed ID: 19717887
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.